A detailed history of Hap Trading, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hap Trading, LLC holds 18,100 shares of LLY stock, worth $14.4 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
18,100
Previous 19,300 6.22%
Holding current value
$14.4 Million
Previous $2.43 Billion 37.19%
% of portfolio
0.18%
Previous 0.29%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $4.15 Million - $4.72 Million
13,981 New
13,981 $4.52 Million
Q2 2020

Aug 10, 2020

BUY
$136.42 - $164.18 $5.89 Million - $7.09 Million
43,191 New
43,191 $7.09 Million
Q4 2019

Feb 11, 2020

SELL
$106.92 - $132.43 $1.43 Million - $1.77 Million
-13,339 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $1.94 Million - $2.11 Million
-18,178 Reduced 57.68%
13,339 $1.49 Million
Q4 2018

Feb 12, 2019

BUY
$105.9 - $118.64 $3.34 Million - $3.74 Million
31,517 New
31,517 $3.65 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.